🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/06/1979 | 1,67 | 1,70 | 1,67 | 1,69 | +0,99% | 1,78% | 1.792.080 |
| 04/06/1979 | 1,66 | 1,67 | 1,66 | 1,67 | +0,60% | 0,60% | 773.424 |
| 01/06/1979 | 1,66 | 1,68 | 1,66 | 1,66 | +0,00% | 0,80% | 1.139.386 |
| 31/05/1979 | 1,66 | 1,67 | 1,66 | 1,66 | +0,20% | 1,00% | 2.056.176 |
| 30/05/1979 | 1,68 | 1,68 | 1,66 | 1,66 | -1,38% | 0,99% | 3.429.475 |
| 29/05/1979 | 1,69 | 1,69 | 1,68 | 1,68 | -0,39% | 0,98% | 1.788.307 |
| 25/05/1979 | 1,68 | 1,70 | 1,67 | 1,69 | +0,39% | 1,58% | 2.324.045 |
| 24/05/1979 | 1,70 | 1,70 | 1,68 | 1,68 | -1,17% | 1,56% | 7.760.650 |
| 23/05/1979 | 1,71 | 1,72 | 1,70 | 1,70 | -0,39% | 1,36% | 2.301.408 |
| 22/05/1979 | 1,71 | 1,72 | 1,71 | 1,71 | +0,00% | 0,97% | 1.682.669 |
| 21/05/1979 | 1,71 | 1,73 | 1,71 | 1,71 | +0,19% | 0,97% | 1.505.347 |
| 18/05/1979 | 1,72 | 1,73 | 1,70 | 1,71 | -0,77% | 1,92% | 1.029.974 |
| 17/05/1979 | 1,68 | 1,73 | 1,68 | 1,72 | +2,36% | 2,76% | 2.467.411 |
| 16/05/1979 | 1,71 | 1,71 | 1,67 | 1,68 | -2,12% | 2,52% | 4.368.902 |
| 15/05/1979 | 1,72 | 1,74 | 1,71 | 1,72 | -0,39% | 1,73% | 4.448.131 |
| 14/05/1979 | 1,73 | 1,73 | 1,72 | 1,72 | -0,38% | 0,96% | 1.014.883 |
| 11/05/1979 | 1,70 | 1,74 | 1,69 | 1,73 | +1,95% | 2,74% | 1.324.253 |
| 10/05/1979 | 1,72 | 1,72 | 1,70 | 1,70 | -2,29% | 1,54% | 3.263.472 |
| 09/05/1979 | 1,76 | 1,76 | 1,73 | 1,74 | -1,13% | 1,51% | 2.112.768 |
| 08/05/1979 | 1,73 | 1,77 | 1,72 | 1,76 | +1,34% | 2,48% | 2.761.690 |
| 07/05/1979 | 1,76 | 1,76 | 1,73 | 1,73 | -2,06% | 1,51% | 2.199.542 |
| 04/05/1979 | 1,79 | 1,80 | 1,77 | 1,77 | -1,29% | 1,67% | 1.237.478 |
| 03/05/1979 | 1,80 | 1,81 | 1,79 | 1,79 | -0,37% | 0,92% | 2.067.494 |
| 02/05/1979 | 1,81 | 1,81 | 1,80 | 1,80 | -0,91% | 0,92% | 2.897.510 |
| 01/05/1979 | 1,82 | 1,82 | 1,81 | 1,82 | +0,00% | 0,73% | 4.119.898 |
| 30/04/1979 | 1,80 | 1,83 | 1,80 | 1,82 | +0,92% | 1,66% | 3.769.027 |
| 27/04/1979 | 1,78 | 1,81 | 1,78 | 1,80 | +1,31% | 1,67% | 2.542.867 |
| 26/04/1979 | 1,76 | 1,78 | 1,74 | 1,78 | +0,94% | 2,26% | 1.852.445 |
| 25/04/1979 | 1,75 | 1,76 | 1,74 | 1,76 | +0,76% | 1,33% | 1.709.078 |
| 24/04/1979 | 1,73 | 1,75 | 1,73 | 1,75 | +0,96% | 1,15% | 5.474.333 |